IMCC 6-K
IM Cannabis Corp. (IMCC)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026 (Report No. 6)
Commission File Number: 001-40065
IM Cannabis Corp.
(Exact Name of Registrant as Specified in Charter)
Kibbutz Glil Yam, Central District, Israel 4690500
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
CONTENTS
Resignation of a Director
On September 27, 2026, Ms. Einat Zakariya notified the board of directors of IM Cannabis Corp. (the “Company”) of her resignation from her position as a member of the board of directors of the Company and all committees thereof, effective September 27, 2026. Ms. Zakariya’s resignation was not related to any disagreement with the Company on any matter relating to its operations, policies or practices.
Press Release
On September 28, 2026, the Company issued a press release titled: “IM Cannabis Provides Corporate Update”. A copy of this press release is furnished herewith as Exhibit 99.1.
Incorporation by Reference
This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File Nos. 333-296637, 333-293236, 333-289571 and 333-288346) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.
EXHIBIT INDEX
| Exhibit No. | |
| 99.1 | Press Release dated September 28, 2026, titled “IM Cannabis Provides Corporate Update”. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| IM CANNABIS CORP. | ||
| (Registrant) | ||
| Date: September 28, 2026 | By: | /s/ Oren Shuster |
| Name: | Oren Shuster | |
| Title: | Chief Executive Officer and Director | |
Exhibit 99.1
IM Cannabis Provides Corporate Update
VANCOUVER and GLIL YAM, Israel, September 28, 2026 - IM Cannabis Corp. (“IMCC” or the “Company”) (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, announces that Einat Zakariya resigned as a director of the Company and as a member of all committees of the board of directors of the Company, effective September 27, 2026, for personal reasons.
The board of directors and management of the Company thank Einat Zakariya for her service and valuable contributions during her tenure and extend their best wishes to her in her future endeavours.
About IM Cannabis Corp.
IMCC (Nasdaq: IMCC) is an international company currently operating a medical cannabis platform serving patients in Israel and, through Adjupharm GmbH, Germany. As previously announced on August 17, 2026, the Company has entered into an agreement to sell I.M.C. Holdings Ltd. Upon completion of that transaction, the Company expects to retain its Israeli medical cannabis operations, while the German operations conducted through Adjupharm GmbH are expected to be held indirectly by the purchaser.
The IMCC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms in Israel that enable the safe delivery and quality control of IMCC’s products throughout the value chain.
Company Contact:
Michal Efraty
Investor & Public Relations
IM Cannabis Corp.
[email protected]
Oren Shuster, Chief Executive Officer
IM Cannabis Corp.